At the moment, risk stratification in Hypertrophic Cardiomyopathy relies on the application of clinical scores which have been shown to have only a moderate discriminative capacity in predicting sudden cardiac death and/or arrhythmic events. Cardiac magnetic resonance can estimate the amount of myocardial fibrosis which is thought to constitute the substrate for life-threatening ventricular arrhythmias. This CME will help to understand the role of cardiac magnetic resonance in improving risk stratification of Hypertrophic Cardiomyopathy. After this activity learners will understand the capability of cardiac magnetic resonance in detecting myocardial fibrosis, correctly estimate the amount of late gadolinium enhancement, and understand how cardiac magnetic resonance can improve risk stratification in patients with Hypertrophic Cardiomyopathy.
The Society for Cardiovascular Magnetic Resonance (SCMR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The Society for Cardiovascular Magnetic Resonance (SCMR) designates this Journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Instructions for Claiming CME
- Attend the sessions in full for which credit is sought
- Complete the post-activity evaluation
- A certificate of completion will be available once the evaluation is submitted
The planners and faculty for this activity did not have any relationships to disclose.
Disclosure of Commercial Support
SCMR received funding to support this activity from the following organizations:
Please see the bibliography at the end of the journal article.